Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Jul 1;11(6):e1570. doi: 10.1002/wnan.1570

Figure 4.

Figure 4.

NCI nanotechnology R01 applications versus all NCI R01 applications submitted. The graph highlights the changing level of investigator-initiated R01 applications submitted in the last decade. Applications received and reviewed for nanotechnology (solid blue bars) in comparison with the total number of applications received and reviewed (solid grey bars) displays persistent increase in nanotechnology for cancer being researched by the biomedical research community. The proportion (black text percentiles) of nanotechnology applications to the total submitted highlights this increase. The data was obtained using an internal NIH grant database and contains information on both new and re-submitted grants. Nanotechnology submissions were identified using a search with the NIH RCDC (Research, Condition, and Disease Categorization) term of “nano”.